Galactosidases

Name
Galactosidases
Accession Number
DBCAT000216
Description

A family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage. EC 3.2.1.-.

Drugs
DrugDrug Description
Agalsidase betaA recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide.
TilactaseA beta-D-galactosidase use to treat lactose intolerance.
Agalsidase alfaA recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide.
Pegunigalsidase alfaA recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease.
Drugs & Drug Targets
DrugTargetType
Agalsidase betaGlobotriaosylceramidetarget
Agalsidase betaCation-dependent mannose-6-phosphate receptortransporter
TilactaseLactosetarget
Agalsidase alfaCation-dependent mannose-6-phosphate receptortransporter
Agalsidase alfaGlobotriaosylceramidetarget
Pegunigalsidase alfaGlobotriaosylceramidetarget
Pegunigalsidase alfaAlpha-galactosidase Atarget